Inducible COX-2-dependent apoptosis in human ovarian cancer cells

Cassie Lin, Dana R. Crawford, Sharon Lin, Jualang Hwang, Annette Sebuyira, Ran Meng, Jennifer E. Westfall, Heng Yuan Tang, SuFan F. Lin, Pin Yung Yu, Paul J. Davis, Hung Yun Lin

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Resveratrol is a naturally occurring trihydroxyl-diphenylethylene compound that has been shown experimentally to have beneficial effects in the treatment of cancer and cardiovascular disease. Resveratrol induces programmed cell death (apoptosis) in these cells and activates important signal transducing proteins including extracellular signal-regulated kinases (ERKs) 1 and 2 in cancer cells. Resveratrol also causes nuclear accumulation of the enzyme cyclooxygenase (COX)-2 and of the oncogene suppressor protein, p53. We have studied the molecular basis of the anticancer actions of resveratrol using human ovarian carcinoma (OVCAR-3) cells. Our findings include the following: (i) nuclear accumulation of COX-2 in resveratrol-treated cells is blocked by the ERK1/2 inhibitor, PD98059; (ii) an inhibitor of COX-2 activity, NS398, prevents accumulation of ERK1/2, COX-2, activated p53 and small ubiquitin-like modifier (SUMO-1) in the nucleus; (iii) apoptosis, quantitated by nucleosome enzyme-linked immunosorbent assay and the nuclear abundance of the pro-apoptotic protein, BcL-xs, were inhibited by NS398. This finding implicates nuclear COX-2 in p53-mediated apoptosis induced by resveratrol. Sumoylation is important to stabilization of p53 and a COX-2-SUMO-1 interaction suggests sumoylation of COX-2 in resveratrol-treated cells and (iv) chromatin immunoprecipitation studies showed binding of induced nuclear COX-2 to the promoter region of PIG3 and Bax, pro-apoptotic gene targets of transcriptionally active p53. Nuclear accumulation of activated ERK1/2 and sumolyated COX-2 are essential to resveratrolinduced pSer-15-p53-mediated apoptosis in human ovarian cancer cells.

Original languageEnglish
Pages (from-to)19-26
Number of pages8
JournalCarcinogenesis
Volume32
Issue number1
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Cyclooxygenase 2
Ovarian Neoplasms
Apoptosis
Sumoylation
Apoptosis Regulatory Proteins
Mitogen-Activated Protein Kinase 3
Nucleosomes
Cyclooxygenase 2 Inhibitors
Chromatin Immunoprecipitation
Oncogene Proteins
Mitogen-Activated Protein Kinase 1
Ubiquitin
resveratrol
Genetic Promoter Regions
Neoplasms
Cell Death
Cardiovascular Diseases
Enzyme-Linked Immunosorbent Assay
Carcinoma
Enzymes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Lin, C., Crawford, D. R., Lin, S., Hwang, J., Sebuyira, A., Meng, R., ... Lin, H. Y. (2011). Inducible COX-2-dependent apoptosis in human ovarian cancer cells. Carcinogenesis, 32(1), 19-26. https://doi.org/10.1093/carcin/bgq212

Inducible COX-2-dependent apoptosis in human ovarian cancer cells. / Lin, Cassie; Crawford, Dana R.; Lin, Sharon; Hwang, Jualang; Sebuyira, Annette; Meng, Ran; Westfall, Jennifer E.; Tang, Heng Yuan; Lin, SuFan F.; Yu, Pin Yung; Davis, Paul J.; Lin, Hung Yun.

In: Carcinogenesis, Vol. 32, No. 1, 2011, p. 19-26.

Research output: Contribution to journalArticle

Lin, C, Crawford, DR, Lin, S, Hwang, J, Sebuyira, A, Meng, R, Westfall, JE, Tang, HY, Lin, SF, Yu, PY, Davis, PJ & Lin, HY 2011, 'Inducible COX-2-dependent apoptosis in human ovarian cancer cells', Carcinogenesis, vol. 32, no. 1, pp. 19-26. https://doi.org/10.1093/carcin/bgq212
Lin C, Crawford DR, Lin S, Hwang J, Sebuyira A, Meng R et al. Inducible COX-2-dependent apoptosis in human ovarian cancer cells. Carcinogenesis. 2011;32(1):19-26. https://doi.org/10.1093/carcin/bgq212
Lin, Cassie ; Crawford, Dana R. ; Lin, Sharon ; Hwang, Jualang ; Sebuyira, Annette ; Meng, Ran ; Westfall, Jennifer E. ; Tang, Heng Yuan ; Lin, SuFan F. ; Yu, Pin Yung ; Davis, Paul J. ; Lin, Hung Yun. / Inducible COX-2-dependent apoptosis in human ovarian cancer cells. In: Carcinogenesis. 2011 ; Vol. 32, No. 1. pp. 19-26.
@article{e0ba535ae7f3482e9351920978b7a3c1,
title = "Inducible COX-2-dependent apoptosis in human ovarian cancer cells",
abstract = "Resveratrol is a naturally occurring trihydroxyl-diphenylethylene compound that has been shown experimentally to have beneficial effects in the treatment of cancer and cardiovascular disease. Resveratrol induces programmed cell death (apoptosis) in these cells and activates important signal transducing proteins including extracellular signal-regulated kinases (ERKs) 1 and 2 in cancer cells. Resveratrol also causes nuclear accumulation of the enzyme cyclooxygenase (COX)-2 and of the oncogene suppressor protein, p53. We have studied the molecular basis of the anticancer actions of resveratrol using human ovarian carcinoma (OVCAR-3) cells. Our findings include the following: (i) nuclear accumulation of COX-2 in resveratrol-treated cells is blocked by the ERK1/2 inhibitor, PD98059; (ii) an inhibitor of COX-2 activity, NS398, prevents accumulation of ERK1/2, COX-2, activated p53 and small ubiquitin-like modifier (SUMO-1) in the nucleus; (iii) apoptosis, quantitated by nucleosome enzyme-linked immunosorbent assay and the nuclear abundance of the pro-apoptotic protein, BcL-xs, were inhibited by NS398. This finding implicates nuclear COX-2 in p53-mediated apoptosis induced by resveratrol. Sumoylation is important to stabilization of p53 and a COX-2-SUMO-1 interaction suggests sumoylation of COX-2 in resveratrol-treated cells and (iv) chromatin immunoprecipitation studies showed binding of induced nuclear COX-2 to the promoter region of PIG3 and Bax, pro-apoptotic gene targets of transcriptionally active p53. Nuclear accumulation of activated ERK1/2 and sumolyated COX-2 are essential to resveratrolinduced pSer-15-p53-mediated apoptosis in human ovarian cancer cells.",
author = "Cassie Lin and Crawford, {Dana R.} and Sharon Lin and Jualang Hwang and Annette Sebuyira and Ran Meng and Westfall, {Jennifer E.} and Tang, {Heng Yuan} and Lin, {SuFan F.} and Yu, {Pin Yung} and Davis, {Paul J.} and Lin, {Hung Yun}",
year = "2011",
doi = "10.1093/carcin/bgq212",
language = "English",
volume = "32",
pages = "19--26",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Inducible COX-2-dependent apoptosis in human ovarian cancer cells

AU - Lin, Cassie

AU - Crawford, Dana R.

AU - Lin, Sharon

AU - Hwang, Jualang

AU - Sebuyira, Annette

AU - Meng, Ran

AU - Westfall, Jennifer E.

AU - Tang, Heng Yuan

AU - Lin, SuFan F.

AU - Yu, Pin Yung

AU - Davis, Paul J.

AU - Lin, Hung Yun

PY - 2011

Y1 - 2011

N2 - Resveratrol is a naturally occurring trihydroxyl-diphenylethylene compound that has been shown experimentally to have beneficial effects in the treatment of cancer and cardiovascular disease. Resveratrol induces programmed cell death (apoptosis) in these cells and activates important signal transducing proteins including extracellular signal-regulated kinases (ERKs) 1 and 2 in cancer cells. Resveratrol also causes nuclear accumulation of the enzyme cyclooxygenase (COX)-2 and of the oncogene suppressor protein, p53. We have studied the molecular basis of the anticancer actions of resveratrol using human ovarian carcinoma (OVCAR-3) cells. Our findings include the following: (i) nuclear accumulation of COX-2 in resveratrol-treated cells is blocked by the ERK1/2 inhibitor, PD98059; (ii) an inhibitor of COX-2 activity, NS398, prevents accumulation of ERK1/2, COX-2, activated p53 and small ubiquitin-like modifier (SUMO-1) in the nucleus; (iii) apoptosis, quantitated by nucleosome enzyme-linked immunosorbent assay and the nuclear abundance of the pro-apoptotic protein, BcL-xs, were inhibited by NS398. This finding implicates nuclear COX-2 in p53-mediated apoptosis induced by resveratrol. Sumoylation is important to stabilization of p53 and a COX-2-SUMO-1 interaction suggests sumoylation of COX-2 in resveratrol-treated cells and (iv) chromatin immunoprecipitation studies showed binding of induced nuclear COX-2 to the promoter region of PIG3 and Bax, pro-apoptotic gene targets of transcriptionally active p53. Nuclear accumulation of activated ERK1/2 and sumolyated COX-2 are essential to resveratrolinduced pSer-15-p53-mediated apoptosis in human ovarian cancer cells.

AB - Resveratrol is a naturally occurring trihydroxyl-diphenylethylene compound that has been shown experimentally to have beneficial effects in the treatment of cancer and cardiovascular disease. Resveratrol induces programmed cell death (apoptosis) in these cells and activates important signal transducing proteins including extracellular signal-regulated kinases (ERKs) 1 and 2 in cancer cells. Resveratrol also causes nuclear accumulation of the enzyme cyclooxygenase (COX)-2 and of the oncogene suppressor protein, p53. We have studied the molecular basis of the anticancer actions of resveratrol using human ovarian carcinoma (OVCAR-3) cells. Our findings include the following: (i) nuclear accumulation of COX-2 in resveratrol-treated cells is blocked by the ERK1/2 inhibitor, PD98059; (ii) an inhibitor of COX-2 activity, NS398, prevents accumulation of ERK1/2, COX-2, activated p53 and small ubiquitin-like modifier (SUMO-1) in the nucleus; (iii) apoptosis, quantitated by nucleosome enzyme-linked immunosorbent assay and the nuclear abundance of the pro-apoptotic protein, BcL-xs, were inhibited by NS398. This finding implicates nuclear COX-2 in p53-mediated apoptosis induced by resveratrol. Sumoylation is important to stabilization of p53 and a COX-2-SUMO-1 interaction suggests sumoylation of COX-2 in resveratrol-treated cells and (iv) chromatin immunoprecipitation studies showed binding of induced nuclear COX-2 to the promoter region of PIG3 and Bax, pro-apoptotic gene targets of transcriptionally active p53. Nuclear accumulation of activated ERK1/2 and sumolyated COX-2 are essential to resveratrolinduced pSer-15-p53-mediated apoptosis in human ovarian cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=79952117930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952117930&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgq212

DO - 10.1093/carcin/bgq212

M3 - Article

VL - 32

SP - 19

EP - 26

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 1

ER -